← Back to Search

Augmented Reality for Biopsies

N/A

Recruiting

Led By Karun Sharma, MD, PhD

Research Sponsored by Children's National Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient referred to Interventional Radiology for image-guided needle injection, aspiration, or biopsy.

Male or female, ages 3 to 21

Must not have

Patients over 300 pounds

Patients who are unable to give informed consent themselves or through their parents

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test if using a virtual reality system during MRI-guided needle procedures is safe and possible.

Who is the study for?

This trial is for patients who need MRI-guided needle procedures, such as biopsies or treatments for infections and pain. The study aims to test if using an augmented reality system can help with these procedures.

What is being tested?

The intervention being studied is an augmented reality system designed to assist during MRI-guided needle interventions. The trial will assess the feasibility and safety of this technology in a clinical setting.

What are the potential side effects?

Since this trial involves a non-invasive technology, side effects may be minimal but could include discomfort from wearing the device or potential distractions leading to procedural complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am referred for a procedure using imaging to guide needle use.

Select...

I am between 3 and 21 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I weigh over 300 pounds.

Select...

I cannot give consent for the trial myself or through my parents.

Select...

I am under 3 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Clinical impressions of the system use and utility

Number of MRI scans

Procedure time

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients Undergoing Augmented Reality Image-Guided Needle ProceduresExperimental Treatment1 Intervention

Patients will undergo their standard of care image-guided needle biopsy, aspiration, or injection with the Augmented Reality system. Patients will be monitored for adverse events for two weeks following their procedure.

0 / 5Eligibility criteria met